John D. Stanton serves as Executive at MTS MEDICATION TECHNOLOGIES, INC /DE/, where they oversee executive responsibilities. Since joining the company, John D. Stanton has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 22, 2009 involved selling 10,286 shares valued at $0.
John D. Stanton currently holds 10,286 shares of MTS MEDICATION TECHNOLOGIES, INC /DE/ (MPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John D. Stanton has been a net neutral trader of MPP stock. They have purchased $0 and sold $0 worth of shares.
John D. Stanton's most recent insider trade was on Dec 22, 2009, when they sold 10,286 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 9, 2007 | MPP | $0 | Award | 1,000 | $N/A | Discretionary |